Product name:EKB-569
CAS:257933-82-7
Description:EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib.
EKB-569
Send Enquiry Online
This form is unable to receive your inquiry from aol, hotmail, gmail or others but company email address.For more information OR other products. Please contact us by Email, Tel, Fax or Send online enquiry. We will reply you as soon as possible.
1. Email: sales@chemicalspharm.com
2. Tel: +86 592 5365868